Class IIReported 2024-12-18

Levothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC 0378-1809-77) and b) 1000-count bottles (NDC 0378-1809-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

Recalled by Viatris Inc

Reason for Recall

Superpotent Drug and Subpotent Drug: potency failures obtained

Recall Number

D-0127-2025

Classification

Class II

Status

Ongoing

Category

drug

Initiated

2024-11-18

Reported

2024-12-18

Distribution

Nationwide within the United States and Puerto Rico

Code Info

Lot #: a) 8171269, Exp. Date Feb 2025; 8179579, Exp. Date July 2025 b)3183815, Exp. Date Nov 2024; 3189147, Exp. Date Jan 2025; 3192027, Exp. Date Feb 2025; 3202894, Exp. Date Jul 2025; 3192026, Exp. Date Feb 2025; 3199781, Exp. Date Jun 2025. 3192028, exp. date Feb 2025 3202895, exp. date July 2025

Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.